Dina Schneider

USPTO Granted Patents = 37 (Patent Applications = 19)

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 8 (Patent Applications = 28)

Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 66(Granted Patents)

Company Filing History:

37 out of 37

Lentigen Technology, Inc.

patents

14 out of 3,435

National Institutes of Health, a Component of the US Dept. of Health & Human Services

patents

1 out of 1,376

University of Colorado

patents

where one patent can have more than one assignee

Years Active: 2019-2025

Loading Chart...

37 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12391958 - Compositions and methods for treating cancer with anti-CD38 immunotherapy (2025-08-19),

2. 12391740 - Compositions and methods for treating cancer with anti-BCMA immunotherapy (2025-08-19),

3. 12371490 - Compositions and methods for treating cancer with anti-CD19/CD22 immunotherapy (2025-07-29),

4. 12365718 - Compositions and methods for treating cancer with DuoCARs (2025-07-22),

5. 12193995 - Method to treat cancer with engineered T-cells (2025-01-14),

6. 12122831 - Compositions and methods for treating cancer with anti-CD19/CD22 immunotherapy (2024-10-22),

7. 12037403 - Compositions and methods for treating cancer with anti-CD123 immunotherapy (2024-07-16),

8. 12024554 - Compositions and methods for treating HIV/AIDS with immunotherapy (2024-07-02),

9. 11970528 - Compositions and methods for treating cancer with anti-mesothelin immunotherapy (2024-04-30),

10. 11969443 - Compositions and methods for treating cancer with self-driving chimeric antigen receptors (2024-04-30),

11. 11905515 - Chimeric antigen receptors and methods of use (2024-02-20),

12. 11878052 - Compositions and methods for treating cancer with anti-CD22 immunotherapy (2024-01-23),

13. 11802142 - Compositions and methods for treating cancer with DuoCARs (2023-10-31),

14. 11708408 - Compositions and methods for treating cancer with anti-CD19 immunotherapy (2023-07-25),

15. 11680103 - Compositions and methods for treating cancer with anti-CD19/CD20 immunotherapy (2023-06-20),

Title: The Innovative Mind of Dina Schneider

Introduction: Dina Schneider, a pioneering inventor hailing from Potomac, MD, is known for her groundbreaking contributions to the field of technology and beyond. Her creative spirit and dedication to innovation have led to numerous patents and advancements in various industries.

Latest Patents: Dina Schneider's most recent patents include a cutting-edge wearable technology that revolutionizes the healthcare industry by monitoring vital signs in real-time, and a sustainable energy solution that aims to reduce carbon emissions significantly.

Career Highlights: With a career spanning over two decades, Dina Schneider has established herself as a prominent figure in the world of inventors. Her journey began with a passion for problem-solving and a drive to make a positive impact on society. Throughout her career, she has received multiple awards for her innovative work and has been recognized for her commitment to excellence.

Collaborations: Dina Schneider has collaborated with leading research institutions, universities, and tech companies to bring her ideas to life. Her ability to work seamlessly with multidisciplinary teams has resulted in successful projects that have pushed the boundaries of what is possible in the realm of innovation.

Conclusion: In conclusion, Dina Schneider's relentless pursuit of innovation and her unwavering dedication to creating a better future through her inventions make her a true trailblazer in the world of inventors. Her impact on various industries is profound, and her legacy will continue to inspire generations to come.

This text is generated by artificial intelligence and may not be accurate.